Conference Detail



Pharmacy Conference Details

College of Psychiatric and Neurologic Pharmacists (CPNP) 2014 Annual Meeting CME

Date:
April 27-30, 2014
Location:
Phoenix, Arizona 85044, United States
Email:
Description:
Learning Objectives
  • Practice using select DSM-5 assessment tools and rating scales in order to implement the changes to the DSM.
  • Analyze evidence-based data on the role of antipsychotics as “mood stabilizers” in the maintenance treatment of bipolar disorder.
  • Evaluate evidence-based literature regarding polypharmacy in psychiatric disorders.
  • Evaluate the potential medical benefits and risks associated with medical marijuana use.
  • Review current approaches to patients with treatment resistant depression.
  • Identify innovative pharmacy practice models and discuss their role in clinical practice.
  • Discuss the role of oxytocin in the management of negative symptoms in schizophrenia.
  • Analyze the reasons for and impact of shortages of medications commonly used in electroconvulsive therapy.
  • Contrast the role of non-pharmacologic treatment with pharmacotherapy in patients with eating disorders.
  • Examine the impact of obesity in society, its prevalence in mental illness, and the pathophysiologic basis of the emerging role of the hormone leptin.
  • Explain the value of pharmacist-provided comprehensive medication management as part of the team approach to care for patients with mental illnesses.
  • Understand the validity and reliability of clinical predictions of violence and the effectiveness of treatment and interventions to reduce violence risk in persons with serious mental illnesses.
  • And more...
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Venue: Arizona Grand Resort
Conference Full List

Prepare for This Meeting

Read Article Summaries From Top Medical Journals

1 AAN issues findings on use of medical marijuana in treatment of certain brain diseases American Academy of Neurology News, April 29, 2014

2 AAN calls for more research on medical marijuana for brain diseases American Academy of Neurology News, December 18, 2014

3 Herbal cannabis not recommended for rheumatology patients EurekAlert!, March 4, 2014 Free full text

4 The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: A preliminary study Neuropsychiatric Disease and Treatment, July 24, 2014 Free full text

5 Antipsychotics and amotivation Neuropsychopharmacology, February 13, 2015

Related Quizzes From Smartest Doc

Question: Compared to other psychotropics in the outpatient setting, antipsychotic use in patients with dementia is associated with a:

Question: Which statement regarding the onset of diabetes mellitus (DM) in geriatric patients using psychotropic medications is INCORRECT?

Question: Which outcome is associated with the use of antipsychotic drugs to treat Behavioral and Psychological Symptoms of Dementia (BPSD) in older patients with dementia?

Latest Pharmacy Articles

 

Be Ready for Upcoming 2015 Board Exams!

Be prepared for board reviews with confidence with 1000s of board exam style questions. Prepare Here